Founded at TU Munich. Driven by precision, purpose, and the will to change lives.
Investment & Growth
For our next development and growth phase, we plan to combine approximately €1 million in public funding with a targeted €700,000 investment. This allows private capital to be effectively leveraged and deployed directly into validation, market entry, and scaling our technology.
Request an investor meeting →Revolutionizing vibration control — from Munich to the world. Up to 99.9% reduction enables breakthrough performance in MedTech, manufacturing, aerospace, and emergency transport.
SDG 9 – Industry, Innovation and InfrastructureFrom student research to company founding — in close collaboration with Germany's leading universities. A springboard for entrepreneurship and translational research.
SDG 8.b – Decent Work and Economic GrowthMore than 500,000 vibration-sensitive patient transports take place in Germany alone every year. Our technology reduces risks and improves survival chances.
SDG 3 – Good Health and Well-BeingFounding idea, first awards and competition successes.
Luca and Sebastian met at TU Munich and recognized the enormous potential of active vibration damping for medical transport. First proof-of-concepts were developed and the TUM IDEAward 2023 was won.
Market validation, first real pilot and EXIST funding.
In early 2024, Luca and Sebastian applied to the XPLORE program. Upon acceptance, they expanded the team, conducted market analyses, identified neonatal transport as the primary target market, and launched a realistic pilot project with Munich Fire Department, Heart Center, and neonatology experts. Over 10 Letters of Intent confirmed broad interest. EXIST funding was approved.
Full-time development, ESA BIC funding and growing strategic partnerships.
After completing their studies, Luca and Sebastian started full-time at Muniqo. Admission to the ESA BIC program, team expansion, and pilot project phase 2. First place at the Munich Impact Incubator, finalist at TUM Pitch Perfect and Generation D.
From pilot to certification, first clinical installations and initial sales.
By mid-2026, product development will be completed, Phase 3 validates the system in neonatal helicopter transport. CE marking (MDR risk class I) and patent finalized. First installations and sales in the second half of the year.
Standard for critical transport and expansion into new billion-dollar markets.
By 2030, Muniqo will be established as the standard solution for vibration-free patient transport. Over 500 systems installed. Expansion into vibration diagnostics. Target: healthcare market > €350M, multi-billion-dollar markets and measurable impact — saving lives.
